Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion type Assertion NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_head.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_provenance.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion evidence source_evidence_literature NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_provenance.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion SIO_000772 21041608 NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_provenance.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion wasDerivedFrom gad-20150221 NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_provenance.
- NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_assertion wasGeneratedBy ECO_0000203 NP187873.RAsKk1lQmjM65efR7jXUUE6lDVO3HVZNBYCBsMZoch-B4130_provenance.